Position in SABS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
78,733
-0.1% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SABS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Clear Street Group Inc. holds $10,625,646 across 13 Biotechnology names. SABS ranks #7 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SRPT |
Sarepta Therapeutics, Inc.
|
361,391 | $7,863,868 | |
| 2 | CNTN |
Canton Strategic Holdings, Inc.
|
652,243 | $2,132,834 | |
| 3 | MRNA |
Moderna, Inc.
|
11,008 | $559,206 | |
| 4 | NTRB |
NutriBand Inc.
|
61,590 | $68,980 | |
| 5 | ARTL |
Artelo Biosciences, Inc.
|
100 | $758 | |
| 6 | ICU |
SeaStar Medical Holding Corp
|
46,490 | $0 | |
| 7 | SABS |
SAB Biotherapeutics, Inc.
This page
|
78,733 | $0 | |
| 8 | REVB |
Revelation Biosciences, Inc.
|
247,534 | $0 |
All Filings in SABS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 SABSW | — | 78,733 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 SABSW | — | 78,833 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 SABSW | — | 79,033 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||